ResearcherThe University of SydneyNo recent work listed
Bekesho Geleta
Matched on ORCID iD 0000-0002-4546-9692; OpenAlex author ID A5112603870. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper
Papers 3
- Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1. Co-author DOI 10.1016/j.jbc.2022.101608↗
- Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma. Co-author DOI 10.1096/fj.202002279r↗
- The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells. Co-author DOI 10.1093/carcin/bgy178↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Žaklina Kovačević · 3 shared papers, 2019–2022 · strength 0.39
- Paper Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the m… DOI 10.1016/j.jbc.2022.101608↗
- Paper Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and str… DOI 10.1096/fj.202002279r↗
- Paper The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin express… DOI 10.1093/carcin/bgy178↗
- Des Raymond Richardson · 3 shared papers, 2019–2022 · strength 0.39
- Paper Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the m… DOI 10.1016/j.jbc.2022.101608↗
- Paper Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and str… DOI 10.1096/fj.202002279r↗
- Paper The metastasis suppressor, NDRG1, attenuates oncogenic TGF-β and NF-κB signaling to enhance membrane E-cadherin express… DOI 10.1093/carcin/bgy178↗
- Minoti Vivek Apte · 2 shared papers, 2021–2022 · strength 0.29
- Paper Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the m… DOI 10.1016/j.jbc.2022.101608↗
- Paper Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and str… DOI 10.1096/fj.202002279r↗
- Sumit Sahni · 2 shared papers, 2021–2022 · strength 0.29
- Paper Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the m… DOI 10.1016/j.jbc.2022.101608↗
- Paper Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and str… DOI 10.1096/fj.202002279r↗
- Zhihong Xu · 1 shared paper, 2021 · strength 0.12
- Marina Pajic · 1 shared paper, 2021 · strength 0.12
- Sharleen V. Menezes · 1 shared paper, 2019 · strength 0.10
- Alexander Richardson · 1 shared paper, 2019 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.